Discover trends, market shifts, and competitive outlooks for the digital therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Digital Therapeutics Market In 2029?

The market size for digital therapeutics has experienced exponential growth over the past few years. It is expected to rise from $8.73 billion in 2024 to $10.99 billion in 2025, with a compound annual growth rate (CAGR) of 25.9%. This growth during the historic period is largely due to factors such as an aging population, an increase in chronic disease, the adoption of digital health, cost-effectiveness in healthcare, remote monitoring of patients, and a surge in demand due to the pandemic.

It is estimated that the digital therapeutics market will experience significant growth in the upcoming years, with a projected size of $30.04 billion by 2029. This represents a compound annual growth rate (CAGR) of 28.6%. Factors contributing to this expected growth during the forecast period include the rising implementation of personalized medicine, the interoperability of health data, and value-based care models. Moreover, the increased emphasis on mental health and well-being, equity in healthcare access, enhanced cybersecurity and data protection, as well as the escalating demand for population health management, are driving this expansion. Notable trends forecasted within this period consist of the proliferation of IoT devices and sensors, the incorporation of artificial intelligence in healthcare, the rise of wearable health technology, technological progress, and product breakthroughs.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5343&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Digital Therapeutics Market?

The anticipated surge in the digital therapeutics market is largely attributed to the rising prevalence of smartphones and tablets, in combination with healthcare applications. These mobile-driven healthcare solutions offer a host of advantages, such as reducing the incidence of medication errors, promoting preventative care, and supporting accurate staffing. Take, for instance, the State of Mobile Internet Connectivity Report 2023 by the UK’s non-profit organization, Groupe Speciale Mobile Association (GSMA), which predicts that over half the global population (54%) will own a smartphone by 2022. Hence, the ballooning smartphone usage is a significant driver for the expansion of the digital therapeutics market.

Which Key Market Segments Comprise the Digital Therapeutics Market and Drive Its Revenue Growth?

The digital therapeutics market covered in this report is segmented –

1) By Product: Software, Devices

2) By Sales Channel: Business-To-Business (B2B), Business-To-Consumers (B2C)

3) By Application: Preventive Applications, Treatment Or Care-Related Applications

Subsegments:

1) By Software: Mobile Applications, Web-Based Platforms, Digital Therapeutics Software

2) By Devices: Wearable Devices, Biosensors, Digital Therapeutic Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=5343&type=smp

Which Areas Are Leading Regions in the Digital Therapeutics Market Expansion Across the Globe?

North America was the largest region in the digital therapeutics market in 2024. The Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Key Market Trends in theDigital Therapeutics Market Over the Coming Years?

The rise in technological innovation is a noteworthy trend that is experiencing increased popularity in the digital therapeutics market. Major firms actively participating in this market are directing their focus to the creation of state-of-the-art solutions in digital therapeutics to reinforce their presence in the sector. For example, Boehringer Ingelheim, a German pharmaceutical firm, and Click Pharmaceuticals, a US prescription digital therapeutics enterprise, have initiated a collaboration to develop and commercialize a digital remedy for schizophrenia patients, with an estimated value exceeding $500 million. Named CT-155, this treatment will take the form of a mobile application, developed using Click’s technology platform, as stated by the company.

View the full report here:

https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report

How Is the Digital Therapeutics Market Conceptually Defined?

Digital therapeutics (DTx) are the products that give evidence-based therapeutic treatments to patients through high-quality software applications in order to prevent, manage, or treat a medical ailment or disease.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5343

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model